Related references
Note: Only part of the references are listed.Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor - Role of oxidative stress
Miki Nagase et al.
HYPERTENSION (2007)
Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor
Caroline Ronzaud et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis
Aaron M. Ring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Podocyte as the target for aldosterone - Roles of oxidative stress and Sgk1
Shigeru Shibata et al.
HYPERTENSION (2007)
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Jane A. Leopold et al.
NATURE MEDICINE (2007)
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors
Miki Nagase et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Aldosterone blockade: An emerging strategy for abrogating progressive renal disease
Murray Epstein
AMERICAN JOURNAL OF MEDICINE (2006)
Podocyte lesions in patients with obesity-related glomerulopathy
Hui-Mei Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms
Florian Lang et al.
PHYSIOLOGICAL REVIEWS (2006)
Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1
Ferruh Artune et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Plasma aldosterone is independently associated with the metabolic syndrome
Murielle Bochud et al.
HYPERTENSION (2006)
Involvements of rho-kinase and TGF-β pathways in aldosterone-induced renal injury
Guang-Ping Sun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Renal damage in primary aldosteronism - Results of the PAPY study
Gian Paolo Rossi et al.
HYPERTENSION (2006)
Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker
Miki Nagase et al.
HYPERTENSION (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Mechanisms of disease: Hereditary proteinuria syndromes and mechanisms of proteinuria
K Tryggvason et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The role of aldosterone in renal sodium transport
DJ Rozansky
SEMINARS IN NEPHROLOGY (2006)
Body mass index and risk for end-stage renal disease
CY Hsu et al.
ANNALS OF INTERNAL MEDICINE (2006)
Metabolic syndrome and CKD in a general Japanese population: The Hisayama study
Toshiharu Ninomiya et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Metabolic syndrome and chronic kidney disease in Okinawa, Japan
H Tanaka et al.
KIDNEY INTERNATIONAL (2006)
Obesity, proteinuria and progression of renal failure
Manuel Praga et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Mechanisms of mineralocorticoid action
PJ Fuller et al.
HYPERTENSION (2005)
Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: More complicated than we thought
DM Stocco et al.
MOLECULAR ENDOCRINOLOGY (2005)
Association between body mass index and CKD in apparently healthy men
RP Gelber et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
Y Nagai et al.
HYPERTENSION (2005)
Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells
K Miyata et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation
K Ishizawa et al.
HYPERTENSION (2005)
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria
M Quinkler et al.
CIRCULATION (2005)
SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess
V Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A
Y Terada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
M Kurella et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
From the periphery of the glomerular capillary wall toward the center of disease - Podocyte injury comes of age in diabetic nephropathy
G Wolf et al.
DIABETES (2005)
Aldosterone and end-organ damage
NJ Brown
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2005)
Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis
M Ruano et al.
OBESITY SURGERY (2005)
Relative glomerular hyperfiltration in primary aldosteronism
J Ribstein et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Expression and regulation of adrenomedullin in renal glomerular podocytes
M Hino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability
A Nishiyama et al.
HYPERTENSION (2005)
Weight loss and the renin-angiotensin-aldosterone system
S Engeli et al.
HYPERTENSION (2005)
Aldosterone biosynthesis, regulation, and classical mechanism of action
G Williams
HEART FAILURE REVIEWS (2005)
Body mass index and the risk of development of end-stage renal disease in a screened cohort
K Iseki et al.
KIDNEY INTERNATIONAL (2004)
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension
GH Williams et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats
A Nishiyama et al.
HYPERTENSION (2004)
Resistant hypertension, obesity, sleep apnea, and aldosterone - Theory and therapy
TL Goodfriend et al.
HYPERTENSION (2004)
Predictors of new-onset kidney disease in a community-based population
CS Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The metabolic syndrome and chronic kidney disease in US adults
J Chen et al.
ANNALS OF INTERNAL MEDICINE (2004)
Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion
TL Goodfriend et al.
HYPERTENSION (2004)
Obesity wars: Molecular progress confronts an expanding epidemic
JS Flier
CELL (2004)
Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome
J Reiser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress
B Lewko et al.
KIDNEY INTERNATIONAL (2004)
Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition
J Ortmann et al.
HYPERTENSION (2004)
Activation of a local tissue angiotensin system in podocytes by mechanical strain
RV Durvasula et al.
KIDNEY INTERNATIONAL (2004)
Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration
RB de Paula et al.
HYPERTENSION (2004)
Sodium intake affects urinary albumin excretion especially in overweight subjects
JC Verhave et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development - A possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone
S Keidar et al.
CIRCULATION (2004)
Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule
P Meneton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Human adipocytes secrete mineralocorticoid-releasing factors
M Ehrhart-Bornstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Aldosterone in chronic kidney and cardiac disease
TH Hostetter et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
50th anniversary of aldosterone
JS Williams et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension
WB White et al.
HYPERTENSION (2003)
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
ER Blasi et al.
KIDNEY INTERNATIONAL (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Dietary salt regulates renal SGK1 abundance - Relevance to salt sensitivity in the Dahl rat
M Farjah et al.
HYPERTENSION (2003)
Aldosterone in renal disease
HN Ibrahim et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2003)
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
A Sato et al.
HYPERTENSION (2003)
Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase
C Kitiyakara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Cell biology of the glomerular podocyte
H Pavenstadt et al.
PHYSIOLOGICAL REVIEWS (2003)
Aldosterone-induced inflammation in the rat heart - Role of oxidative stress
Y Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Aldosterone induces a vascular inflammatory phenotype in the rat heart
R Rocha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Sgk1 gene expression in kidney and its regulation by aldosterone: Spatio-temporal heterogeneity and quantitative analysis
JH Hou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Obesity and renal disease
RD Adelman
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
A Chrysostomou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Human hypertension caused by mutations in WNK kinases
FH Wilson et al.
SCIENCE (2001)
Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift
M Epstein
JOURNAL OF HYPERTENSION (2001)
Molecular mechanisms of human hypertension
RP Lifton et al.
CELL (2001)
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome
N Boute et al.
NATURE GENETICS (2000)
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis
JM Kaplan et al.
NATURE GENETICS (2000)
Share Paper
